questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Inflammation
Suppuration
Empyème
Empyème pleural
Empyème pleural : Questions médicales fréquentes
Termes MeSH sélectionnés :
Mechanistic Target of Rapamycin Complex 2
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Empyème pleural : Questions médicales les plus fréquentes",
"headline": "Empyème pleural : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Empyème pleural : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Empyème pleural"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Empyème",
"url": "https://questionsmedicales.fr/mesh/D004653",
"about": {
"@type": "MedicalCondition",
"name": "Empyème",
"code": {
"@type": "MedicalCode",
"code": "D004653",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.470.756.305"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Empyème tuberculeux",
"alternateName": "Empyema, Tuberculous",
"url": "https://questionsmedicales.fr/mesh/D004654",
"about": {
"@type": "MedicalCondition",
"name": "Empyème tuberculeux",
"code": {
"@type": "MedicalCode",
"code": "D004654",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.470.756.305.250.320"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Empyème pleural",
"alternateName": "Empyema, Pleural",
"code": {
"@type": "MedicalCode",
"code": "D016724",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cheng-Li Lin",
"url": "https://questionsmedicales.fr/author/Cheng-Li%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Management Office for Health Data, China Medical University Hospital , Taichung, Taiwan."
}
},
{
"@type": "Person",
"name": "Te-Chun Shen",
"url": "https://questionsmedicales.fr/author/Te-Chun%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, No. 2, Yude Road, Taichung, 404, Taiwan."
}
},
{
"@type": "Person",
"name": "Danail B Petrov",
"url": "https://questionsmedicales.fr/author/Danail%20B%20Petrov",
"affiliation": {
"@type": "Organization",
"name": "Medical University - Sofia, Sofia, Bulgaria."
}
},
{
"@type": "Person",
"name": "Dragan Subotic",
"url": "https://questionsmedicales.fr/author/Dragan%20Subotic",
"affiliation": {
"@type": "Organization",
"name": "University Hospital Basel, Basel, Switzerland."
}
},
{
"@type": "Person",
"name": "Georgi S Yankov",
"url": "https://questionsmedicales.fr/author/Georgi%20S%20Yankov",
"affiliation": {
"@type": "Organization",
"name": "Medical University - Sofia, Sofia, Bulgaria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mechanistic target of rapamycin signaling in human nervous system development and disease.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36226315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnmol.2022.1005631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of dual mTORC1/2 inhibitor AZD8055 and mTORC1 inhibitor rapamycin on the metabolism of breast cancer cells using proton nuclear magnetic resonance spectroscopy metabolomics.",
"datePublished": "2022-09-05",
"url": "https://questionsmedicales.fr/article/36063263",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10637-022-01268-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Involvement of Mechanistic Target of Rapamycin (mTOR) in Valine Orexigenic Effects in Rainbow Trout.",
"datePublished": "2022-09-27",
"url": "https://questionsmedicales.fr/article/36860456",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7509382"
}
},
{
"@type": "ScholarlyArticle",
"name": "The mechanistic target of rapamycin complex 1 pathway involved in hepatic gluconeogenesis through peroxisome-proliferator-activated receptor γ coactivator-1",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/36204284",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aninu.2022.07.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Roles of phosphatidylserine and phospholipase C in the activation of TOR complex 2 signaling in Saccharomyces cerevisiae.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/35912799",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1242/jcs.259988"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Inflammation",
"item": "https://questionsmedicales.fr/mesh/D007249"
},
{
"@type": "ListItem",
"position": 5,
"name": "Suppuration",
"item": "https://questionsmedicales.fr/mesh/D013492"
},
{
"@type": "ListItem",
"position": 6,
"name": "Empyème",
"item": "https://questionsmedicales.fr/mesh/D004653"
},
{
"@type": "ListItem",
"position": 7,
"name": "Empyème pleural",
"item": "https://questionsmedicales.fr/mesh/D016724"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Empyème pleural - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Empyème pleural",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Empyème pleural",
"description": "Comment diagnostique-t-on un empyème pleural ?\nQuels tests sont utilisés pour confirmer un empyème ?\nQuels signes cliniques indiquent un empyème ?\nL'imagerie est-elle toujours nécessaire ?\nPeut-on confondre un empyème avec une autre condition ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Empyème pleural",
"description": "Quels sont les symptômes principaux d'un empyème ?\nL'empyème provoque-t-il des douleurs ?\nY a-t-il des symptômes systémiques associés ?\nLes symptômes varient-ils selon l'âge ?\nUn empyème peut-il être asymptomatique ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Empyème pleural",
"description": "Comment prévenir un empyème pleural ?\nLes vaccinations aident-elles à prévenir l'empyème ?\nY a-t-il des mesures d'hygiène à respecter ?\nLes personnes âgées sont-elles plus à risque ?\nLe traitement des maladies chroniques aide-t-il ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Empyème pleural",
"description": "Quel est le traitement principal de l'empyème ?\nDes antibiotiques sont-ils nécessaires ?\nQuand une intervention chirurgicale est-elle requise ?\nLe traitement est-il différent chez les enfants ?\nQuels soins de suivi sont nécessaires après traitement ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Empyème pleural",
"description": "Quelles sont les complications possibles d'un empyème ?\nL'empyème peut-il entraîner des séquelles ?\nComment prévenir les complications ?\nLes complications sont-elles fréquentes ?\nQuelles sont les conséquences d'une septicémie liée à un empyème ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Empyème pleural",
"description": "Quels sont les principaux facteurs de risque d'empyème ?\nLes antécédents médicaux influencent-ils le risque ?\nLe système immunitaire joue-t-il un rôle ?\nLes conditions de vie affectent-elles le risque ?\nLes maladies pulmonaires chroniques sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D016724?mesh_terms=Mechanistic+Target+of+Rapamycin+Complex+2&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un empyème pleural ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (radiographie, échographie) et analyse du liquide pleural."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer un empyème ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une thoracocentèse permet d'analyser le liquide pleural pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un empyème ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur thoracique, dyspnée et toux productive sont des signes fréquents."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle toujours nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'imagerie est essentielle pour évaluer l'étendue de l'empyème et guider le traitement."
}
},
{
"@type": "Question",
"name": "Peut-on confondre un empyème avec une autre condition ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec une pneumonie ou un abcès pulmonaire sans analyse précise."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux d'un empyème ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleur thoracique et essoufflement."
}
},
{
"@type": "Question",
"name": "L'empyème provoque-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur thoracique est fréquente, souvent aggravée par la respiration ou la toux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme fatigue, malaise général et perte d'appétit peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent présenter des symptômes moins spécifiques que les adultes."
}
},
{
"@type": "Question",
"name": "Un empyème peut-il être asymptomatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, un empyème peut être asymptomatique, surtout à ses débuts."
}
},
{
"@type": "Question",
"name": "Comment prévenir un empyème pleural ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par le traitement rapide des infections pulmonaires et des maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir l'empyème ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre la pneumonie peuvent réduire le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures d'hygiène à respecter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et éviter le tabagisme peuvent aider à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'empyème en raison de leur santé générale."
}
},
{
"@type": "Question",
"name": "Le traitement des maladies chroniques aide-t-il ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle des maladies chroniques peut réduire le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'empyème ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est le drainage du liquide pleural, souvent par thoracocentèse."
}
},
{
"@type": "Question",
"name": "Des antibiotiques sont-ils nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques sont prescrits pour traiter l'infection sous-jacente."
}
},
{
"@type": "Question",
"name": "Quand une intervention chirurgicale est-elle requise ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est nécessaire si le drainage ne suffit pas ou en cas de complications."
}
},
{
"@type": "Question",
"name": "Le traitement est-il différent chez les enfants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement est similaire, mais les doses et les approches peuvent varier selon l'âge."
}
},
{
"@type": "Question",
"name": "Quels soins de suivi sont nécessaires après traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est essentiel pour surveiller la guérison et prévenir les récidives."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'un empyème ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pleurale, l'insuffisance respiratoire et la septicémie."
}
},
{
"@type": "Question",
"name": "L'empyème peut-il entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles comme des douleurs thoraciques chroniques ou des limitations respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et approprié de l'empyème est essentiel pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir, surtout si l'empyème n'est pas traité rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une septicémie liée à un empyème ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La septicémie peut entraîner un choc septique, des défaillances d'organes et un risque de mortalité."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'empyème ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires, le tabagisme et les maladies chroniques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de pneumonie ou de chirurgie thoracique augmentent le risque d'empyème."
}
},
{
"@type": "Question",
"name": "Le système immunitaire joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un système immunitaire affaibli augmente le risque d'infections et d'empyème."
}
},
{
"@type": "Question",
"name": "Les conditions de vie affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de vie précaires ou surpeuplées peuvent augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires chroniques sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la BPCO augmentent le risque d'empyème en raison de l'inflammation."
}
}
]
}
]
}
Mechanistic target of rapamycin (mTOR) is a highly conserved serine/threonine kinase that regulates fundamental cellular processes including growth control, autophagy and metabolism. mTOR has key func...
Dual mTORC1/2 inhibitors may be more effective than mTORC1 inhibitor rapamycin. Nevertheless, their metabolic effects on breast cancer cells have not been reported. We compared the anti-proliferative ...
This study was aimed at clarifying the importance of a mechanistic target of rapamycin (mTOR) in the central orexigenic effect of valine in fish. For this, rainbow trout (...
Cattle can efficiently perform de novo generation of glucose through hepatic gluconeogenesis to meet post-weaning glucose demand. Substantial evidence points to cattle and non-ruminant animals being c...
Target of rapamycin (TOR) forms two distinct complexes, TORC1 and TORC2, to exert its essential functions in cellular growth and homeostasis. TORC1 signaling is regulated in response to nutrients such...
Mechanistic target of rapamycin kinase (mTOR) is a member of the phosphatidylinositol-3-hydroxide kinase (PI3 K)-related protein kinase family that functions as a central regulator of cell growth, met...
Enhancing hepatic gluconeogenesis is one of the main modes of meeting the glucose requirement of dairy cows. This study attempted to determine whether the gluconeogenesis precursor propionate had an e...
We investigated whether the infiltration of tumor-infiltrating lymphocytes (TILs) in gastric cancer (GC), as evaluated by hematoxylin and eosin (H&E) staining, could be a prognostic marker. We als...
A total of 183 patients with available data on TIL were included. TIL infiltration was evaluated using H&E staining. We also conducted immunohistochemistry to determine mTOR expression....
Positive TIL infiltration was defined as TILs ≥20%. There were 72 (39.3%) and 111 (60.7%) positive and negative cases, respectively. TILs positivity significantly correlated with both absence of lymph...
mTOR possibly suppresses TIL infiltration in GC. H&E staining is an effective tool for evaluating the immune status of GC patients. H&E staining may be used in clinical practice to monitor tre...
The mechanistic target of rapamycin (mTOR) pathway has been implicated in promoting epileptogenesis in animal models of acquired epilepsy, such as posttraumatic epilepsy (PTE) following traumatic brai...
An adeno-associated virus (AAV)-Cre viral vector was injected into the hippocampus of Rptor...
AAV-Cre injection primarily affected the dentate gyrus and inhibited hippocampal mTOR activation following CCI injury. AAV-Cre-injected mice had reduced neuronal death in dentate gyrus detected by Flu...
mTOR pathway activation in dentate gyrus granule cells may at least partly mediate pathological abnormalities and epileptogenesis in models of TBI and PTE. Targeted modulation of mTOR activity in this...
Mechanistic target of rapamycin (mTOR) C1 and its downstream effectors have been implicated in synaptic plasticity and memory. Our prior work demonstrated that reactivation of cocaine memory engages a...